http://pr.gaeatimes.com Mon, 21 Nov 2011 13:29:44 +0000 http://wordpress.org/?v=2.7.1 en hourly 1 http://pr.gaeatimes.com/first-3-in-1-blood-pressure-pill-now-available-in-the-uk-53721/ http://pr.gaeatimes.com/first-3-in-1-blood-pressure-pill-now-available-in-the-uk-53721/#comments Mon, 21 Nov 2011 05:00:00 +0000 Daiichi Sankyo http://pr.gaeatimes.com/first-3-in-1-blood-pressure-pill-now-available-in-the-uk-53721/ First 3-in-1 Blood Pressure Pill now Available in the UK.]]> http://pr.gaeatimes.com/first-3-in-1-blood-pressure-pill-now-available-in-the-uk-53721/feed/ http://pr.gaeatimes.com/european-survey-highlights-the-risk-to-patients-caused-by-inconsistency-in-hypertension-management-47691/ http://pr.gaeatimes.com/european-survey-highlights-the-risk-to-patients-caused-by-inconsistency-in-hypertension-management-47691/#comments Fri, 08 Jul 2011 05:00:00 +0000 Daiichi Sankyo http://pr.gaeatimes.com/european-survey-highlights-the-risk-to-patients-caused-by-inconsistency-in-hypertension-management-47691/ European Survey Highlights the Risk to Patients Caused by Inconsistency in Hypertension Management.]]> http://pr.gaeatimes.com/european-survey-highlights-the-risk-to-patients-caused-by-inconsistency-in-hypertension-management-47691/feed/ http://pr.gaeatimes.com/global-phase-iii-trial-with-selective-c-met-inhibitor-tivantinib-arq-197-starts-enrolling-patients-in-europe-44124/ http://pr.gaeatimes.com/global-phase-iii-trial-with-selective-c-met-inhibitor-tivantinib-arq-197-starts-enrolling-patients-in-europe-44124/#comments Mon, 18 Apr 2011 05:00:00 +0000 Daiichi Sankyo http://pr.gaeatimes.com/global-phase-iii-trial-with-selective-c-met-inhibitor-tivantinib-arq-197-starts-enrolling-patients-in-europe-44124/ Global Phase III Trial With Selective c-MET Inhibitor Tivantinib (ARQ 197) Starts Enrolling Patients in Europe.]]> http://pr.gaeatimes.com/global-phase-iii-trial-with-selective-c-met-inhibitor-tivantinib-arq-197-starts-enrolling-patients-in-europe-44124/feed/ http://pr.gaeatimes.com/daiichi-sankyo-and-arqule-enroll-first-non-small-cell-lung-cancer-patient-into-global-phase-iii-trial-for-arq-197-39978/ http://pr.gaeatimes.com/daiichi-sankyo-and-arqule-enroll-first-non-small-cell-lung-cancer-patient-into-global-phase-iii-trial-for-arq-197-39978/#comments Wed, 12 Jan 2011 05:00:00 +0000 Daiichi Sankyo http://pr.gaeatimes.com/daiichi-sankyo-and-arqule-enroll-first-non-small-cell-lung-cancer-patient-into-global-phase-iii-trial-for-arq-197-39978/ Daiichi Sankyo and ArQule Enroll First Non-Small Cell Lung Cancer Patient Into Global Phase III Trial for ARQ 197.]]> http://pr.gaeatimes.com/daiichi-sankyo-and-arqule-enroll-first-non-small-cell-lung-cancer-patient-into-global-phase-iii-trial-for-arq-197-39978/feed/ http://pr.gaeatimes.com/daiichi-sankyo-announces-first-european-approval-for-sevikar-hctr-a-new-three-in-one-combination-product-for-the-treatment-of-high-blood-pressure-39406/ http://pr.gaeatimes.com/daiichi-sankyo-announces-first-european-approval-for-sevikar-hctr-a-new-three-in-one-combination-product-for-the-treatment-of-high-blood-pressure-39406/#comments Mon, 20 Dec 2010 05:00:00 +0000 Daiichi Sankyo http://pr.gaeatimes.com/daiichi-sankyo-announces-first-european-approval-for-sevikar-hctr-a-new-three-in-one-combination-product-for-the-treatment-of-high-blood-pressure-39406/ Daiichi Sankyo Announces First European Approval for Sevikar HCT(R), a New Three-in-one Combination Product for the Treatment of High Blood Pressure*.]]> http://pr.gaeatimes.com/daiichi-sankyo-announces-first-european-approval-for-sevikar-hctr-a-new-three-in-one-combination-product-for-the-treatment-of-high-blood-pressure-39406/feed/ http://pr.gaeatimes.com/daiichi-sankyo-completes-enrollment-of-the-edoxaban-global-phase-iii-engage-af-timi-48-study-in-patients-with-atrial-fibrillation-38694/ http://pr.gaeatimes.com/daiichi-sankyo-completes-enrollment-of-the-edoxaban-global-phase-iii-engage-af-timi-48-study-in-patients-with-atrial-fibrillation-38694/#comments Wed, 01 Dec 2010 05:00:00 +0000 Daiichi Sankyo http://pr.gaeatimes.com/daiichi-sankyo-completes-enrollment-of-the-edoxaban-global-phase-iii-engage-af-timi-48-study-in-patients-with-atrial-fibrillation-38694/ Read more >>.]]> http://pr.gaeatimes.com/daiichi-sankyo-completes-enrollment-of-the-edoxaban-global-phase-iii-engage-af-timi-48-study-in-patients-with-atrial-fibrillation-38694/feed/ http://pr.gaeatimes.com/update-daiichi-sankyo-completes-enrollment-of-the-edoxaban-global-phase-iii-engage-af-timi-48-study-in-patients-with-atrial-fibrillation-38712/ http://pr.gaeatimes.com/update-daiichi-sankyo-completes-enrollment-of-the-edoxaban-global-phase-iii-engage-af-timi-48-study-in-patients-with-atrial-fibrillation-38712/#comments Wed, 01 Dec 2010 05:00:00 +0000 Daiichi Sankyo http://pr.gaeatimes.com/update-daiichi-sankyo-completes-enrollment-of-the-edoxaban-global-phase-iii-engage-af-timi-48-study-in-patients-with-atrial-fibrillation-38712/ Read more >>.]]> http://pr.gaeatimes.com/update-daiichi-sankyo-completes-enrollment-of-the-edoxaban-global-phase-iii-engage-af-timi-48-study-in-patients-with-atrial-fibrillation-38712/feed/ http://pr.gaeatimes.com/arqule-and-daiichi-sankyo-expand-drug-discovery-collaboration-in-oncology-36422/ http://pr.gaeatimes.com/arqule-and-daiichi-sankyo-expand-drug-discovery-collaboration-in-oncology-36422/#comments Tue, 12 Oct 2010 05:00:00 +0000 Daiichi Sankyo http://blog.taragana.com/pr/arqule-and-daiichi-sankyo-expand-drug-discovery-collaboration-in-oncology-36422/ Original article  : ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology.]]> http://pr.gaeatimes.com/arqule-and-daiichi-sankyo-expand-drug-discovery-collaboration-in-oncology-36422/feed/ http://pr.gaeatimes.com/new-high-resolution-computer-tomography-data-demonstrates-evistars-effect-on-bone-quality-in-osteoporotic-patients-23062/ http://pr.gaeatimes.com/new-high-resolution-computer-tomography-data-demonstrates-evistars-effect-on-bone-quality-in-osteoporotic-patients-23062/#comments Mon, 28 Jun 2010 05:00:00 +0000 Daiichi-sankyo http://blog.taragana.com/pr/new-high-resolution-computer-tomography-data-demonstrates-evistars-effect-on-bone-quality-in-osteoporotic-patients-23062/ New High-Resolution Computer Tomography Data Demonstrates EVISTA(R)'s Effect on Bone Quality in Osteoporotic Patients.]]> http://pr.gaeatimes.com/new-high-resolution-computer-tomography-data-demonstrates-evistars-effect-on-bone-quality-in-osteoporotic-patients-23062/feed/ http://pr.gaeatimes.com/patients-with-hypertension-at-risk-due-to-physician-inertia-22559/ http://pr.gaeatimes.com/patients-with-hypertension-at-risk-due-to-physician-inertia-22559/#comments Mon, 21 Jun 2010 05:00:00 +0000 Daiichi Sankyo http://blog.taragana.com/pr/patients-with-hypertension-at-risk-due-to-physician-inertia-22559/ Read more : Patients with Hypertension at Risk Due to Physician Inertia.]]> http://pr.gaeatimes.com/patients-with-hypertension-at-risk-due-to-physician-inertia-22559/feed/ http://pr.gaeatimes.com/daiichi-sankyo-submits-first-new-drug-application-for-oral-factor-xa-inhibitor-edoxaban-15619/ http://pr.gaeatimes.com/daiichi-sankyo-submits-first-new-drug-application-for-oral-factor-xa-inhibitor-edoxaban-15619/#comments Tue, 06 Apr 2010 05:00:00 +0000 Daiichi Sankyo http://blog.taragana.com/pr/daiichi-sankyo-submits-first-new-drug-application-for-oral-factor-xa-inhibitor-edoxaban-15619/ Read more : Daiichi Sankyo Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban.]]> http://pr.gaeatimes.com/daiichi-sankyo-submits-first-new-drug-application-for-oral-factor-xa-inhibitor-edoxaban-15619/feed/ http://pr.gaeatimes.com/hokusai-vte-largest-single-phase-iii-trial-for-the-treatment-and-prevention-of-recurrent-vte-started-in-europe-13821/ http://pr.gaeatimes.com/hokusai-vte-largest-single-phase-iii-trial-for-the-treatment-and-prevention-of-recurrent-vte-started-in-europe-13821/#comments Fri, 26 Feb 2010 05:00:00 +0000 Daiichi Sankyo http://blog.taragana.com/pr/hokusai-vte-largest-single-phase-iii-trial-for-the-treatment-and-prevention-of-recurrent-vte-started-in-europe-13821/ HOKUSAI VTE - Largest Single Phase III Trial for the Treatment and Prevention of Recurrent VTE Started in Europe.]]> http://pr.gaeatimes.com/hokusai-vte-largest-single-phase-iii-trial-for-the-treatment-and-prevention-of-recurrent-vte-started-in-europe-13821/feed/ http://pr.gaeatimes.com/analysis-of-edoxaban-phase-ii-data-provides-insight-into-reduced-bleeding-events-seen-in-once-daily-dosing-4157/ http://pr.gaeatimes.com/analysis-of-edoxaban-phase-ii-data-provides-insight-into-reduced-bleeding-events-seen-in-once-daily-dosing-4157/#comments Wed, 15 Jul 2009 05:00:00 +0000 Prne http://blog.taragana.com/pr/analysis-of-edoxaban-phase-ii-data-provides-insight-into-reduced-bleeding-events-seen-in-once-daily-dosing-4157/ Read the original article: here.]]> http://pr.gaeatimes.com/analysis-of-edoxaban-phase-ii-data-provides-insight-into-reduced-bleeding-events-seen-in-once-daily-dosing-4157/feed/ http://pr.gaeatimes.com/osteoporosis-drug-heritage-continues-ahead-of-10th-anniversary-2283/ http://pr.gaeatimes.com/osteoporosis-drug-heritage-continues-ahead-of-10th-anniversary-2283/#comments Tue, 19 May 2009 05:00:00 +0000 Prne http://blog.taragana.com/pr/osteoporosis-drug-heritage-continues-ahead-of-10th-anniversary-2283/ Osteoporosis Drug Heritage Continues Ahead of 10th Anniversary.]]> http://pr.gaeatimes.com/osteoporosis-drug-heritage-continues-ahead-of-10th-anniversary-2283/feed/ http://pr.gaeatimes.com/evistar-improves-patient-compliance-in-osteoporosis-management-2284/ http://pr.gaeatimes.com/evistar-improves-patient-compliance-in-osteoporosis-management-2284/#comments Tue, 19 May 2009 05:00:00 +0000 Prne http://blog.taragana.com/pr/evistar-improves-patient-compliance-in-osteoporosis-management-2284/ Read the original article on Gaea Times at : EVISTA(R) Improves Patient Compliance in Osteoporosis Management.]]> http://pr.gaeatimes.com/evistar-improves-patient-compliance-in-osteoporosis-management-2284/feed/